Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Negative Breast Cancer × Goserelin × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 27 Breast Neoplasms 18 Salivary Gland Neoplasms 3 Prostate Adenocarcinoma 2 Breast Neoplasms, Male 2 Stage I Prostate Adenocarcinoma AJCC v7 1 Primary Dysautonomias 1 Patient Compliance 1 PSA Level Greater Than Two 1 Neoplasm Metastasis 1 Kidney Diseases 1 Hypertension 1 Hormone Sensitive Prostate Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 HER2-positive Breast Cancer 1 HER2 Negative Breast Cancer 1 Castrate Sensitive Prostate Cancer 1 Bulbo-Spinal Atrophy, X-Linked 1 Anatomic Stage I Breast Cancer AJCC v8 1 Advanced Prostate Cancer 1

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06953882 2025-07-14

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡